The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

IAB Catheters

As the leader in counterpulsation therapy, Maquet is committed to developing IABs that deliver greater hemodynamic support. That's why we've built on the exceptional track record of the MEGA 8 Fr. 50 cc IAB to create an expanded MEGA family. With the addition of the larger volume MEGA 7.5 Fr. 30 cc and 40 cc IAB, there's now a balloon that delivers superior blood volume displacement for everyone, at any height.

MEGA: Greater hemodynamic support and higher efficacy for every patient.

New Sizing Guidelines

Why Are the New Sizes Better for my Patient?

Adding the new 30cc and 40cc MEGA IAB, the benefits of a larger volume IAB are now also available for patients smaller than 5’4” (< 162cm). Larger volume balloons like MEGA displace more blood in the aorta during diastole, resulting in improved augmentation and unloading.

With these new sizing guidelines, a larger patient population can benefit from greater hemodynamic support than ever before.

Thus, why not consider using a higher efficacy IAB as your FIRST choice when hemodynamic support is needed?

Greater hemodynamic support

Larger volume balloons like MEGA displace more blood in the aorta during diastole, resulting in improved augmentation and unloading.*

More blood volume displacement

More diastolic augmentation

More systolic unloading

STATLOCK® IAB Stabilization Device

All MEGA IABs include two complete and ready-to-use STATLOCK® IAB Stabilization Devices for sutureless securement of IAB catheters, delivering safety and comfort to you and your patients.

Abstract

We report the enhanced augmentation of cardiac output in a 60-year-old man who underwent percutaneous coronary intervention with drug-eluting stent implantation for a large anteroseptal ST-segment-elevation myocardial infarction. Because of persistent systemic hypotension during the procedure, a 50 cc, 8 Fr. MEGA® intra-aortic balloon was inserted, used for 24 hours, and removed without complications. The use of this new balloon — with larger blood volume displacement but smaller caliber at the insertion site — significantly increased cardiac output in 1:1, 1:2, and 1:3 assist modes, by more than 15%, 9%, and 4%, respectively. These findings exceed the average augmentations reported for smaller-volume balloon catheters.

Improvement in Hemodynamics with a New Larger Volume 50cc IAB for High Risk PCI Study

Pradeep K. Nair, MD, Sun Scolieri, MD, Ashley B. Lee, MD

Abstract

A primary cause of adverse outcomes among high-risk patients undergoing percutaneous coronary intervention (PCI) may be a diminished capacity to tolerate the hemodynamic and ischemic insults that can occur during the procedure. A common means of mechanical support during PCI has been the intra-aortic balloon pump (IABP). We describe successful periprocedural mechanical support with a new, 50 cc IABP in a patient with both severe left ventricular dysfunction and extensive coronary arteriosclerosis, for whom PCI with stenting was indicated. The prophylactic use of this 50 cc IABP, which traditionally would be contraindicated because of the patient’s height (162.6 cm), markedly increased the diastolic aortic pressure (by ~110 mmHg) over the baseline level, while promptly reducing left-sided heart pressures. This finding appears to exceed the average diastolic augmentation reported for smaller-volume balloons. Although the role of the IABP in high-risk PCI remains controversial, further research is warranted to clarify and compare this new 50 cc IABP to smaller-volume balloons, and ascertain whether the observed hemodynamic benefits can translate into improved clinical outcomes among patients requiring mechanical support during PCI.

Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, Getinge and Maquet. ArjoHuntleigh focuses on patient mobility and wound management solutions. Getinge provides solutions for infection control within healthcare and contamination prevention within life sciences. Maquet specializes in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.